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INTRODUCTION
Ureteral stone is one of the most common urologic diseases. 
Affected patients can experience extreme pain. There are many 
options for ureteral stone treatment [e.g., shock wave litho-
tripsy (SWL), and ureteroscopic, laparoscopic, or open surgery]. 
Since the 1980s, SWL has been recommended as a non-inva-
sive, effective, first-line treatment for small-sized radio-opaque 
stones (≤2 cm diameter).1 The overall stone-free rate after treat-
ment using SWL is 80–90%.2,3 A patient’s age, sex, and stone 
characteristics (stone site, size, and density) are factors associ-
ated with stone-free rates. The number of stones, a history of 
urolithiasis, presence of renal colic, degree of hydronephrosis, 
and presence of a double J stent are additional factors associ-
ated with stone-free rates after treatment using SWL.4-6 
Ureteral stone is the most common cause of ipsilateral hy-
dronephrosis. The presence of one or more ureteral stones war-
rants urgent intervention to resolve the patient’s symptoms and 
to prevent damage to renal function. The relationship between 
the degree of preoperative hydronephrosis and stone free rate 
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after SWL has been studied. However, unanswered questions 
remain, and a complete understanding would aid clinical de-
cision-making during treatment selection.5-8 We aimed to in-
vestigate the predictors of one-session success rates after treat-
ment using SWL; we specifically focused on the significance of 
pretreatment hydronephrosis in patients with a ureteral stone. 
MATERIALS AND METHODS
Patient cohort
Medical records were obtained from a database of patients (n= 
1824) who underwent an initial session of SWL between No-
vember 2005 and December 2014 at Severance Hospital, Seoul, 
Korea. The study inclusion criteria were a single, 4–20 mm, ra-
diopaque calculus located within the ureter on plain-film X-
rays, presentation within 1 month prior to SWL treatment, and 
no evidence of stone migration. Patients with bilateral ureteral 
stones, urinary tract congenital anomalies, single kidney, con-
comitant medical expulsive treatment, or a history of stone sur-
gery were excluded from the analysis. Data from a total of 700 
patients were eligible for the analysis.
Good clinical practice protocols
The study was performed in accordance with all applicable 
laws and regulations, good clinical practices, and the ethical 
principles described in the Declaration of Helsinki. The Insti-
tutional Review Board of Severance Hospital approved the 
study protocol (4-2016-0791). The study was exempt from the 
need for written informed consent, because of its retrospec-
tive design and because the patients’ records and information 
were anonymized and de-identified before analysis.
Shock wave lithotripsy
SWL was performed using an electro-conductive lithotripter 
(EDAP Sonolith Praktis, Technomed, Lyon, France) until De-
cember 2011. On January 2012, this lithotripter was replaced by 
an electromagnetic generative lithotripter (Dornier Compact 
Delta II lithotripter, Dornier Medtech, Wessling, Germany). 
All SWL procedures were performed under fluoroscopic guid-
ance. The total numbers of shocks ranged from 2500 to 4000 
in each session, at a rate of 60–90 shock waves per minute and 
at a launch intensity ranging from 16 to 55 MPa.
Demographic data and non-contrast computed 
tomography stone characteristics
A detailed medical history that included the number of past 
stone events was obtained for each patient. Stone characteris-
tics, such as location, maximal stone length (MSL), stone het-
erogeneity index (SHI), skin-to-stone distance (SSD), and mean 
stone density (MSD), were evaluated. SSD was measured in 
the axial plane, 45° from the vertical axis.9 MSL was the longest 
stone length measured in three dimensions on non-contrast 
computed tomography (NCCT) images. We used the GE Cen-
tricity system (GE Healthcare Bio-Sciences Corp., Piscataway, 
NJ, USA) for the measuring procedures. MSD was measured 
using bone windows on the magnified axial NCCT image of the 
stone in the maximal diameter; the elliptical region of interest 
incorporated the largest cross-sectional area of the stone with-
out including adjacent soft tissue.10 The SHI was defined as 
the standard deviation of Hounsfield units (HU) in the same 
way used by Lee, et al.11 Successful SWL treatment of the ureter-
al stone was defined as for patients who were rendered stone-
free or had asymptomatic residual fragments ≤3 mm in largest 
stone diameter on simple X-ray at 2 weeks after a single SWL 
treatment and who did not require additional treatment within 
the 3-month follow-up period.12 
Hydronephrosis grading system 
Hydronephrosis was graded according to the degrees of change 
in the upper collecting system and defined using the Society of 
Fetal Ultrasound Grade system.13 Grade 0 hydronephrosis was 
defined as no dilatation of the renal pelvis, with calyceal walls 
opposed to each other. Grade 1 was defined as dilatation of the 
renal pelvis without dilatation of the calyces (could also be 
present in the extra renal pelvis), and no parenchymal atrophy. 
Grade 2 hydronephrosis was defined as dilatation of the renal 
pelvis (mild) and calyces (the pelvicalyceal pattern was re-
tained), and no parenchymal atrophy. Grade 3 was defined as 
moderate dilatation of the renal pelvis and calyces, blunting of 
the fornicies and flattening of the papillae, and possible mild 
cortical thinning. Grade 4 hydronephrosis was defined as gross 
dilatation of the renal pelvis and calyces with a ballooned ap-
pearance, loss of the borders between the renal pelvis, calyces, 
and renal atrophy indicated by the presence of cortical thinning.
Statistical analyses
The statistical comparisons of the continuous variables from 
the patients’ demographic information were performed using 
Student’s or Welch’s two-sample t-tests or the Wilcoxon rank 
sum test. One-way analysis of variance was used for subgroup 
analysis. Categorical variables were compared using Pearson’s 
chi-square tests. Univariate and binomial multivariate logistic 
regression analyses were performed to identify factors that pre-
dicted post-SWL outcomes. To exclude potential multicollinear-
ity between variables, variance inflation factors for these vari-
ables were also analyzed. The statistical analyses were performed 
using R software (version 3.0.3, R Foundation for Statistical Com-
puting, Vienna, Austria; http://www.r-project.org) and SPSS 23 
software (IBM Co., Armonk, NY, USA). 
RESULTS
Table 1 presents the results for the baseline characteristics of the 
700 patients who underwent an initial SWL treatment for single 
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ureteral calculus. The mean patient age for the cohort was 
52.5±13.8 years. The mean MSL and SSD values were 9.2±3.9 
and 110.8±18.9 mm, respectively. The mean MSD and SHI val-
ues were 707.0±272.1 and 244.9±110.1 HU, respectively. The 
results for pretreatment hydronephrosis grade in patients with 
ureteral stone were 76 (10.9%) cases of grade 0, 383 (46.9%) cas-
es of grade 1, 177 (25.3%) cases of grade 2, 100 (14.3%) cases of 
grade 3, and 19 (2.7%) cases of grade 4 hydronephrosis. There 
were 573 (81.9%) cases of upper ureteral stone, 48 (6.9%) cases 
of mid-ureteral stone, and 79 (11.3%) cases of lower ureteral 
stone. The overall one-session success rate was 69.6%. The data 
from the study population were divided into two groups (treat-
ment success or failure). The results indicated that there were 
statistical differences between the two groups in age (51.8±13.8 
years in success group vs. 54.1±13.8 years in failure group; p= 
0.042), MSL (8.3±3.2 vs. 11.2±4.5, respectively; p<0.001), MSD 
(642.6±243.8 vs. 854.3±276.4, respectively; p<0.001), SHI (252.0± 
114.0 vs. 228.5±98.9, respectively; p=0.006), and grade of hydro-
nephrosis (p<0.001). The one-session success rates were 68.4, 
75.0, 75.1, 54.0, and 10.5% for patients with hydronephrosis 
grades 0, 1, 2, 3, and 4, respectively (Table 2). The results indi-
cated a statistically significant association between hydrone-
phrosis grade and the values for MSL and MSD (p<0.001) (Table 
2). The associations between hydronephrosis grade and one-
session success rate and stone location were also significantly 
different (p<0.001). Among three groups with hydronephrosis 
grade 0–1, grade 2, and grades 3–4, there were statistically sig-
nificant differences in sex (p<0.001), MSL (p<0.001), MSD (p< 
0.001), stone location (p<0.022), and one-session success rate 
(p<0.001) (Table 3). The univariate logistic regression models 
revealed that the following predictive factors were associated 
with SWL outcome after ureteral stone treatment: age [odds ra-
tio (OR): 0.988, 95% confidence intervals (CI): 0.976–0.999; p= 
0.043], MSL (OR: 0.822, 95% CI: 0.782–0.861; p<0.001), MSD 
(OR: 0.997, 95% CI: 0.996–0.998; p<0.001), higher SHI (OR: 
1.002, 95% CI: 1.001–1.004; p=0.010), and hydronephrosis grade 
(OR: 0.309, 95% CI: 0.206–0.463; p<0.001). Multivariate analy-
ses revealed that shorter MSL, lower MSD, and higher SHI were 
independent predictors and that hydronephrosis grades 3 and 
4 were negative predictors of one-session success after SWL 
treatment for ureteral stone (Table 4).
DISCUSSION
SWL has been established as the preferred treatment for uri-
nary stones due to its noninvasiveness, few absolute contrain-
dications, and favorable clinical outcomes.14,15 However, if a sat-
isfactory outcome for SWL is not expected for a specific clinical 
situation, then the other benefits (e.g., non-invasiveness) are 
no longer available to the patient. Therefore, it is essential to ac-
curately predict individual treatment outcomes in terms of prop-
er treatment selection for patients who are candidates for SWL. 
Previous studies of SWL success rates have revealed that age, 
sex, and stone characteristics (stone site, size, and density) are 
factors associated with post-treatment stone-free rates.5,8 Num-
Table 1. Comparison of Clinical Characteristics between One-Session Success and Failure after Shock Wave Lithotripsy for Ureteral Stone 
Total cohort Success group Failure group p value
Patients, n 700 487 213
Mean age±SD (yr)   52.5±13.8   51.8±13.8   54.1±13.8    0.042*
Sex, n (%)   0.206†
Male 454 (64.9) 308 (63.2) 146 (68.5)
Female 246 (35.1) 179 (36.8)   67 (31.5)
Mean MSL±SD (mm)   9.2±3.9   8.3±3.2 11.2±4.5 <0.001*
Mean SSD±SD (mm) 110.8±18.9 110.6±18.9   11.1±19.2   0.751*
Mean MSD±SD (HU)   707.0±272.1   642.6±243.8   854.3±276.4 <0.001*
Mean SHI±SD (HU)   244.9±110.1   252.0±114.0 228.5±98.9   0.006*
Hydronephrosis grade, n (%) <0.001†
Grade 0   76 (10.9)   52 (10.7)   24 (11.3)
Grade 1 328 (46.9) 246 (50.5)   82 (38.5)
Grade 2 177 (25.3) 133 (27.3)   44 (20.7)
Grade 3 100 (14.3)   54 (11.1)   46 (21.6)
Grade 4 19 (2.7)   2 (0.4) 17 (8.0)
Stone location, n (%)   0.510†
Upper 573 (81.9) 403 (82.7) 170 (79.8)
Middle 48 (6.9) 30 (6.2) 18 (8.5)
Lower   79 (11.3)   54 (11.1)   25 (11.7)
One-session success, n (%) 487 (69.6) 487 (69.6) 0 (0)
HU, Hounsfield units; MSD, mean stone density; MSL, maximal stone length; SD, standard deviation; SHI, stone heterogeneity index; SSD, skin-to-stone distance.
*Based on Student’s or Welch’s two-sample t-test, †Based on Pearson’s chi-square test with Yates’ continuity correction. 
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ber of stones, a history of urolithiasis, the presence of renal 
colic, the degree of hydronephrosis, and use of a ureteral stent 
are other factors that affect success rate.6 MSL is a potentially 
useful independent predictor of SWL outcome.5,6 Patients with 
larger stones are more likely to experience failure of treatment 
and require further intervention.16 MSD is also an independent 
factor associated with SWL outcome.17 MSD is the mean value 
of the HU of each pixel in a specific stone area and can be easily 
determined from NCCT images using a picture archiving and 
communication system.18 SSD has been extensively investigat-
ed as a predictor of SWL success, but its use remains contro-
versial for patients with ureter stones: SSD has been deemed a 
significant factor in one-half of all published studies.9 Recently, 
SHI was introduced as a novel independent predictor of SWL 
success in patients with ureteral stone and as a useful clinical 
parameter for stone fragility.11 Other studies of stone sites have 
found that treatment of proximal and distal ureteral stones re-
sults in better outcomes, compared with treatment of mid-ure-
teral stones. However, the results of recent studies suggest that 
there are no differences between groups in regards to stone 
site and treatment results.6,19 A history of urolithiasis has been 
reported as a negative factor affecting SWL success.20,21 Ureteral 
stenting is a significant factor affecting stone-free rates.19 Our 
study revealed that MSL, MSD, SHI, and severe hydronephro-
sis were significant predictors of one-session success rate after 
SWL treatment of single ureteral stone.
Several studies have evaluated the effects of preoperative hy-
dronephrosis on the success rate of SWL; their findings have 
been inconsistent.5-8 El-Assmy, et al.7 divided a total of 215 pa-
tients with single distal ureteral stone into two groups accord-
Table 2. Comparison of Clinical Characteristics among Groups According to Hydronephrosis Grade 
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 p value
Patients, n 76 383 177 100 19
Mean age±SD, (yr)   51.1±14.5   51.8±13.8   53.5±13.5   54.1±14.2   52.5±13.4   0.434*
Sex, n (%)   0.029†
Male 55 (72.4) 223 (68.0) 112 (63.3) 52 (52.0) 12 (63.2)
Female 21 (27.6) 105 (32.0)   65 (36.7) 48 (48.0)   7 (36.8)
Mean MSL±SD (mm)   7.9±2.8   8.4±3.5   9.2±3.5 11.7±4.8 13.6±3.3 <0.001*
Mean SSD±SD (mm) 106.8±19.7 110.8±18.5 111.5±18.2 111.0±20.6 116.8±19.3   0.239*
Mean MSD±SD (HU)   694.0±235.4   687.7±283.2   656.2±216.5   809.5±287.5 1026.5±273.8 <0.001*
Mean SHI±SD (HU) 237.1±80.4   238.5±112.6   250.3±108.1   253.7±121.0   287.8±122.0   0.247*
Stone location, n (%) <0.001†
Upper 56 (73.7) 283 (86.3) 145 (81.9) 73 (73.0) 16 (84.2)
Middle 5 (6.6)   9 (2.7) 16 (9.0) 15 (15.0)   3 (15.8)
Lower 15 (19.7)   36 (11.0) 16 (9.0) 12 (12.0) 0 (0.0)
One-session success, n (%) 52 (68.4) 246 (75.0) 133 (75.1) 54 (54.0)   2 (10.5) <0.001†
HU, Hounsfield units; MSD, mean stone density; MSL, maximal stone length; SD, standard deviation; SHI, stone heterogeneity index; SSD, skin-to-stone distance.
*Based on Student’s or Welch’s two-sample t-test, †Based on Pearson’s chi-square test with Yates’ continuity correction.
Table 3. Comparison of Clinical Characteristics among Groups with Pretreatment Hydronephrosis Grades 0–1, Grade 2, and Grades 3–4 
Total cohort Grades 0–1 Grade 2 Grades 3–4 p value
Patients, n 700 581 177 119
Mean age±SD (yr)   52.5±13.8   52.2±13.8   53.5±13.5   53.8±14.0   0.182*
Sex, n (%) <0.001†
Male 454 (64.9) 390 (67.1) 112 (63.3) 64 (53.8) 
Female 246 (35.1) 191 (32.9)   65 (36.7) 55 (46.2)
Mean MSL±SD (mm)   9.2±3.9   8.6±3.4   9.3±3.5 12.0±4.6 <0.001*
Mean SSD±SD (mm) 110.8±18.9 110.5±18.6 111.5±18.3 112.0±20.4   0.535*
Mean MSD±SD (HU)   707.0±272.1   678.9±258.5   656.2±216.5   844.2±295.2 <0.001*
Mean SHI±SD (HU)   244.9±110.1   241.9±107.6   250.4±108.2   259.1±121.3   0.144*
Stone location, n (%) <0.022†
Upper 573 (81.9) 484 (83.3) 145 (81.9) 89 (74.8) 
Middle 48 (6.9) 30 (5.2) 16 (9.0) 18 (15.1)
Lower   79 (11.3)   67 (11.5) 16 (9.0) 12 (10.1) 
One-session success, n (%) 487 431 (74.2) 133 (75.1) 56 (47.1) <0.001†
HU, Hounsfield units; MSD, mean stone density; MSL, maximal stone length; SD, standard deviation; SHI, stone heterogeneity index; SSD, skin-to-stone distance.
*Based on Student’s or Welch’s two-sample t-test, †Based on Pearson’s chi-square test with Yates’ continuity correction.
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ing to the absence or presence of hydronephrosis. There were 
no significant differences between the degree of stone-induced 
hydronephrosis and SWL outcome (83.2% in the non-hydrone-
phrotic group vs. 74.2% in hydronephrotic group; p=0.27). They 
performed a similar study of 284 patients with proximal ureteral 
stone and found that the stone-free rate was 80.3% in the hydro-
nephrotic group, compared with 89.1% in the patients without 
hydronephrosis (p=0.12).7 The results of Wang, et al.’s6 multi-
variate analysis also suggested that hydronephrosis was not a 
significant factor for SWL treatment success rate (OR: 1.272, 
95% CI: 0.471–3.433; p=0.635). In contrast, Kageyama, et al.8 
found that mid to lower ureteral stone and moderate-to-severe 
hydronephrosis were negative predictive factors of SWL treat-
ment success rate. Delakas, et al.5 also found that the likelihood 
of SWL treatment failure increases as the severity of the obstruc-
tion increases; hydronephrosis was associated with poorer re-
sults after SWL treatment (borderline significance; OR: 1.93, 
95% CI: 0.99–3.77; p=0.053). The results of our multivariate anal-
yses indicated that severe hydronephrosis (grades 3 and 4) is 
an independent predictor of a poor outcome after SWL treat-
ment for ureteral stone (Table 4).
Generally, ureteral stones cause sudden ureteral obstruction 
that results in the development of hydronephrosis; continuous 
obstruction results in deterioration of renal function. Hydro-
nephrosis has adverse effects on renal function and decreases 
ureteral peristalsis and hydraulic pressure. These changes may 
adversely affect the expulsion of ureteral stones. This relation-
ship may help explain our results. Severe hydronephrosis can 
also be linked to ureteral stone impaction into the ureteral 
mucosa. Impacted stones are frequently associated with ure-
teral polyps or strictures. A chronically impacted stone may cause 
inflammation and edema of the ureteral wall; these changes 
may also involve the surrounding tissues. The impacted stone 
can thus cause a more complete ureteral obstruction that results 
in severe hydronephrosis. Impacted ureteral stones are more 
difficult to fragment using SWL, because of the lack of a natural 
expansion space for the targeted stones. There are currently 
two clinical definitions used for impacted stones.22 The first 
commonly used definition of impaction is the inability to pass 
a wire or catheter beyond the stone at the initial attempt.23 The 
second definition of impaction is that the stone has remained 
at the same location in the ureter for more than 2 months.24 
Most urologists know that impacted stones are much more 
resistant to treatment using SWL. However, if currently avail-
able definitions for stone impaction are used, it is almost im-
possible to determine whether a specific ureteral stone is im-
pacted at initial diagnosis. For these reasons, severe hydrone-
phrosis can be used as ancillary clinical evidence of ureteral 
stone impaction in patients with ureteral stone when SWL is 
being considered as a primary treatment. European Association 
of Urology (EAU) guidelines recommend laparoscopic ure-
terolithotomy for treatment of large impacted stones when en-
doscopic lithotripsy or SWL has failed.25 However, our study re-
vealed one-session success rates of 54.0% and 10.5% in patients 
with hydronephrosis grades 3 and 4, respectively (Table 2). 
Therefore, even though SWL is less invasive, compared with 
surgical lithotripsy; we are not sure whether physicians should 
offer SWL as a first-line therapy for ureteral stone patients with 
concomitant grade 4 hydronephrosis. Physicians and patients 
should discuss this low SWL performance rate before selec-
Table 4. Univariate and Multivariate Logistic Regression Analysis of Various Clinical Parameters for the Prediction of One-Session Success after-
Shock Wave Lithotripsy
Parameter Odds ratio 95% confidence intervals p value
Univariate analysis
Age 0.988 0.976–0.999   0.043
Sex (male) 0.789 0.558–1.110   0.177
MSL 0.822 0.782–0.861 <0.001
MSD 0.997 0.996–0.998 <0.001
SSD 0.999 0.990–1.007   0.750
SHI 1.002 1.001–1.004   0.010
Stone location 
Upper Reference
Middle 0.703 0.385–1.317   0.259
Lower 0.911 0.554–1.533   0.719
Hydronephrosis Grade 3 & 4 0.309 0.206–0.463 <0.001
Multivariate analysis
Age 0.992 0.979–1.006   0.267
MSL 0.888 0.841–0.934 <0.001
MSD 0.996 0.995–0.997 <0.001
SHI 1.007 1.005–1.010 <0.001
Hydronephrosis Grade 3 & 4 0.601 0.368–0.988   0.043
MSD, mean stone density; MSL, maximal stone length; SHI, stone heterogeneity index; SSD, skin-to-stone distance.
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tion of SWL as a treatment for ureteral stones with accompany-
ing grade 4 hydronephrosis.
This study had some inherent limitations, because the use 
of a retrospective study design may have introduced sampling 
bias. However, we used a relatively large cohort of patients who 
underwent SWL for treatment of single ureteral stone. The pres-
ence of renal stones and anatomical considerations, including 
the location of calyx and renal pelvic stones or stones in the in-
fundibulopelvic angle, were additional possible sources of bias. 
To overcome this type of limitation and more clearly elucidate 
the effects of various stone-related factors on SWL outcomes, 
we limited the study population to patients who only had ure-
teral stones. Unlike previous studies, we also classified hydro-
nephrosis grade into five groups using a current grading sys-
tem. This approach resulted in a better characterization of the 
contribution of hydronephrosis to treatment outcome. Pro-
spective studies that use large sample sizes are needed to con-
firm our results regarding the relationships between pretreat-
ment hydronephrosis and stone clearance.
In conclusion, the presence of grade 3 or 4 hydronephrosis 
before SWL was a negative predictive factor for one-session 
success in patients treated for a single ureteral stone. Severe hy-
dronephrosis can be used as an indicator of possible ureteral 
stone impaction. In the presence of severe hydronephrosis, es-
pecially grade 4 hydronephrosis, physicians should be cau-
tious when choosing and offering SWL as the primary treat-
ment for ureteral stone.
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